What is the average shipment value for India to Switzerland pharmaceutical trade?

$64.1K per consignment across 1,111 shipments.

How many Indian pharmaceutical companies export to Switzerland?

113 Indian companies. Largest: ELI LILLY EXPORT S.A with $13.6M.

How can I find verified Indian pharmaceutical suppliers for Switzerland?

TransData Nexus covers 113 active exporters with shipment history and trade values at transdatanexus.com.

Switzerland to India Pharmaceutical Import (2026) — $71.2M, 113 Foreign Suppliers | TransData Nexus

Q: What certifications do Indian pharmaceutical exporters need to supply Switzerland?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Switzerland to India Pharmaceutical Import (2026) — $71.2M, 113 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Switzerland to India

#	Formulation	Value	Share
1	Insulin	$15.6M	21.9%
2	Serum	$8.9M	12.6%
3	Collagen	$5.5M	7.7%
4	Trastuzumab	$5.4M	7.6%
5	Meropenem	$5.0M	7.1%
6	Daratumumab	$4.1M	5.8%
7	Ibrutinib	$3.8M	5.3%
8	Prednisone	$3.7M	5.1%
9	Everolimus	$2.8M	3.9%
10	Bevacizumab	$2.0M	2.8%
11	Valsartan	$1.9M	2.7%
12	Moxifloxacin	$1.5M	2.1%
13	Mycophenolate	$1.3M	1.9%
14	Lenalidomide	$1.3M	1.9%
15	Ustekinumab	$1.0M	1.5%

India imports 20+ pharmaceutical formulations from Switzerland with a combined trade value of $71.2M. Key products include Insulin ($15.6M), Serum ($8.9M), Collagen ($5.5M), Trastuzumab ($5.4M), Meropenem ($5.0M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,111 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Switzerland to India Trade Routes

1Insulin$15.6M

2Serum$8.9M

3Collagen$5.5M

4Trastuzumab$5.4M

5Meropenem$5.0M

6Daratumumab

Top Switzerland Suppliers to India

1Eli Lilly Export S.a

$13.6M

2Takeda Pharmaceuticals International Ag.

$8.9M

3Novartis Pharma Ag

$7.6M

4Geistlich Pharma Ag

$5.5M

5Pfizer Service Company Bv

$5.1M

Trade Statistics

Total Value$71.2M

Shipments1,111

Indian Exporters113

Switzerland Buyers80

Avg Shipment$64K

Products89

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to Switzerland?

India exported pharmaceuticals worth $71.2M to Switzerland across 1,111 verified shipments.

Who are the top Indian pharmaceutical exporters to Switzerland?

1. ELI LILLY EXPORT S.A — $13.6M. 2. TAKEDA PHARMACEUTICALS INTERNATIONAL AG. — $8.9M. 3. NOVARTIS PHARMA AG — $7.6M. Total: 113 suppliers.

Which companies in Switzerland import pharmaceuticals from India?

1. ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED — $15.7M. 2. NOVARTIS HEALTHCARE PRIVATE LIMITED — $10.6M. 3. ROCHE PRODUCTS (INDIA) PRIVATE LIMITED — $9.1M. 80 buyers total.

What pharmaceutical products does India export most to Switzerland?

1. Insulin ($15.6M, 21.9%); 2. Serum ($8.9M, 12.6%); 3. Collagen ($5.5M, 7.7%); 4. Trastuzumab ($5.4M, 7.6%); 5. Meropenem ($5.0M, 7.1%)

Which ports handle pharmaceutical shipments from India to Switzerland?

Export: . Import: .

Why does Switzerland import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $71.2M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Switzerland?

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Switzerland identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,111 verified shipments from 113 Indian exporters to 80 Switzerland buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

113 Exporters

80 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Switzerland to India Pharmaceutical Import